|
注册号: Registration number: |
ChiCTR2500114825 |
|
最近更新日期: Date of Last Refreshed on: |
2025-12-17 18:23:39 |
|
注册时间: Date of Registration: |
2025-12-17 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
比较上颌前牙区游离龈移植物(FGG)和猪源性可吸收胶原基质膜(MS)作为位点保存封闭材料的效果 |
|
Public title: |
Comparative Evaluation of Free Gingival Graft (FGG) and Porcine-Derived Absorbable Collagen Matrix Membrane (MS) as Sealing Materials for Site Preservation in the Maxillary Anterior Region |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
比较上颌前牙区游离龈移植物(FGG)和猪源性可吸收胶原基质膜(MS)作为位点保存封闭材料的效果 |
|
Scientific title: |
Comparative Evaluation of Free Gingival Graft (FGG) and Porcine-Derived Absorbable Collagen Matrix Membrane (MS) as Sealing Materials for Site Preservation in the Maxillary Anterior Region |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
周俊成 |
研究负责人: |
汤雨龙 |
|
Applicant: |
Juncheng Zhou |
Study leader: |
Yulong Tang |
|
申请注册联系人电话: Applicant telephone: |
+86 189 1157 7739 |
研究负责人电话:
Study leader's |
+86 153 0988 9050 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
17852851988@163.com |
研究负责人电子邮件: Study leader's E-mail: |
tangyulong2009@foxmail.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国辽宁省沈阳市沈河区五里河街道中国人民解放军北部战区总医院口腔科 |
研究负责人通讯地址: |
中国辽宁省沈阳市沈河区五里河街道中国人民解放军北部战区总医院口腔科 |
|
Applicant address: |
Department of Stomatology, General Hospital of Northern Theater Command, People's Liberation Army of China, Wulihe Subdistrict, Shenhe District, Shenyang, Liaoning Province, China |
Study leader's address: |
Department of Stomatology, General Hospital of Northern Theater Command, People's Liberation Army of China, Wulihe Subdistrict, Shenhe District, Shenyang, Liaoning Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
110016 |
研究负责人邮政编码: Study leader's postcode: |
110016 |
|
申请人所在单位: |
中国人民解放军北部战区总医院口腔科 |
||
|
Applicant's institution: |
Department of Stomatology, General Hospital of Northern Theater Command, People's Liberation Army of China |
||
|
研究负责人所在单位: |
中国人民解放军北部战区总医院口腔科 |
||
|
Affiliation of the Leader: |
Department of Stomatology, General Hospital of Northern Theater Command, People's Liberation Army of China |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
Y(2024)259 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国人民解放军北部战区总医院伦理委员会 |
||
|
Name of the ethic committee: |
The Ethics Committee of Northern Theater Command, People's Liberation Army of China |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-10-22 00:00:00 | ||
|
伦理委员会联系人: |
北部战区总医院伦理办公室赵海涛 |
||
|
Contact Name of the ethic committee: |
Zhao Haitao, Ethics Office, General Hospital of Northern Theater Command |
||
|
伦理委员会联系地址: |
中国辽宁省沈阳市沈河区五里河街道中国人民解放军北部战区总医院伦理办公室 |
||
|
Contact Address of the ethic committee: |
Ethics Office, General Hospital of Northern Theater Command, People's Liberation Army of China, Wulihe Street, Shenhe District, Shenyang City, Liaoning Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 24 2885 6577 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
szec2005@163.com |
|
研究实施负责(组长)单位: |
中国人民解放军北部战区总医院口腔科 |
||||||||||||||||||||||
|
Primary sponsor: |
Department of Stomatology, General Hospital of Northern Theater Command, People's Liberation Army |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国辽宁省沈阳市沈河区五里河街道中国人民解放军北部战区总医院口腔科 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Department of Stomatology, General Hospital of Northern Theater Command, People's Liberation Army of China, Wulihe Subdistrict, Shenhe District, Shenyang, Liaoning Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
科研经费 |
||||||||||||||||||||||
|
Source(s) of funding: |
Research Funding |
||||||||||||||||||||||
|
研究疾病: |
无 |
||||||||||||||||||||||
|
Target disease: |
none |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究旨在比较游离龈移植(FGG)和猪源性可吸收胶原基质膜(MS)的牙槽窝密封性能。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study aimed to compare the socket sealing efficacy of free gingival grafts (FGG) and porcine-derived absorbable collagen matrix membranes (MS). |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
排除标准包括:(1)拒绝签署知情同意书者;(2)存在急性的根尖周炎或急性牙周炎,可能影响治疗效果的患者;(3)明显的局部或全身有严重感染者;(4)严重心血管疾病患者;(5)严重过敏体质患者;(6)控制不良的糖尿病患者;(7)高血压等其他全身系统性疾病未控制者;(8)重度吸烟(每天超过10支)患者;(9)肌肉或静脉注射双膦酸盐的患者;(10)放疗化疗史患者;(11)目前正在参加其他临床试验或已完成临床试验但未满六周者;(12)患者精神上无能力或不能理解参与研究的要求;(13)哺乳期、妊娠期妇女或近期有怀孕计划者;(14)依从性差,不愿配合完成各阶段随访者;(15)研究人员认为不适合参与本研究者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Exclusion criteria: (1) Refusal to sign informed consent; (2) Patients with acute apical periodontitis or acute periodontitis that may interfere with treatment outcomes; (3) Significant local or systemic infections; (4) Severe cardiovascular diseases; (5) Severe allergic predisposition; (6) Poorly controlled diabetes mellitus (e.g., HbA1c >7%); (7) Uncontrolled systemic diseases (such as hypertension); (8) Heavy smoking (>10 cigarettes per day); (9) Patients receiving bisphosphonates via intramuscular or intravenous administration; (10) History of radiotherapy or chemotherapy; (11) Current participation in other clinical trials or having completed a clinical trial within the past six weeks; (12) Mental incompetence or inability to understand study requirements; (13) Pregnancy, lactation, or plans for pregnancy; (14) Poor compliance or unwillingness to attend follow-up visits; (15) Patients deemed unsuitable by investigators for participation. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-10-20 00:00:00至 To 2025-10-20 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-11-26 00:00:00 至 To 2025-08-27 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
本实验采用完全随机化分组法。由实验设计者按患者就诊顺序编号然后使用计算机随机数发生器获得随机数,排序完毕后进行分组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
This experiment adopted a completely randomized grouping method. The study designer assigned sequential numbers to patients according to their enrollment order, then used computer-generated random numbers for sorting. Group allocation was performed after the sorting was completed. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
国家生物信息中心(https://ngdc.cncb.ac.cn/gsub/);共享计划时间:试验结束六个月内 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
China National center for Bioinformation (https://ngdc.cncb.ac.cn/gsub/); Data Sharing Plan Timeline: Within 6 months after trial completion |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例报告表、eXamVision软件、相机 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Report Form (CRF) , eXamVisionapp , Camera |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |